Philippe Moreau is Professor of Clinical Hematology and head of the translational research program in hematology and oncology, at the University Hospital of Nantes, France. Professor Moreau’s clinical interests are focused on multiple myeloma and its treatment with high-dose therapy and novel agents.
Professor Moreau is the chairman of the Intergroupe Francophone du Myélome (IFM) since 2020. He is vice-president of International Myeloma Society (IMS) since 2019, and he is a member of the steering committee of the International Myeloma Working Group (IMWG) since 2013. He has served as the principal investigator of several international randomized phase 3 clinical trials. He was a member of the organizing committee for the 2011 International Myeloma Workshop in Paris.
His research is widely published. Professor Moreau has authored or coauthored more than 400 peer-reviewed articles that have appeared in high impact factor journals including, the New England Journal of Medicine, Journal of Clinical Oncology, The Lancet, The Lancet Oncology, and Blood.
Professor Moreau received in 2018 the Robert A. Kyle lifetime achievement award.
EM-93698 - Date of preparation: March 2022